From the Desk of Steve Strazza and Alfonso Depablos
Today’s most significant insider transaction comes in a Form 4 filing by Decheng Capital Management, a hedge fund focused on investing in early-stage life science companies.
For the longest time, investors in the United States have been rewarded for their home country bias and their overexposure to large-caps and growth stocks.
We love our bottoms-up scans here at All Star Charts. We tend to get really creative when making new universes as we want to be sure they will deliver us the best opportunities the market has to...